Dectin-1与非Toll样模式识别受体免疫识别的研究进展.docVIP

Dectin-1与非Toll样模式识别受体免疫识别的研究进展 ? 236?2007年7月第30卷第4期InternationalJournalofImmunology.July2oo7.V0L30.No.4 (1-2):l37—151. 9HeJ,GuDF,WuXG,eta1.MajorgauSesofdeathamongmenand womeninChina.NEnglJMed,2005,353(11):1124—1134. 10WangXJ,YuJJ,SreekumarA,eta1.Autoantibodysignaturesinpros— tatecancer.NewEnglJMed,2005,353(12):1224—1235. 11ZhongL,HidalgoGE,StrombergAJ,eta1.Usingproteinmicroarray asadiagnosticassayfornon—smallcelllungcancer.AmJRespirCrit CareMed,2005,172(10):1308—1314. 12MadridFF,TangN,AlansariH,eta1.AutoantibodiestoannexinXI—A andotherautoantigensinthediagnosisofbreastcancer.CancerRes, 2004,64(15):5089-5096. 13KangN,HamiltonS,OdiliJ,eta1.Invivotargetingofmalignantmel— anomaby125Iodine-?and99mTechnetium-?labeledsingle-.chainFv fragmentsagainsthighmolecularweightmelanoma-?associatedanti-? gen.ClinCancerRes,2000,6(12):4921-4931. 14VitiF,TarliL,GiovannoniL,eta1.Increasedbindingaffinityandva— lenceofrecombinantantibodyfragmentsleadtoimprovedtargetingof tumoralanglogenesis.CancerRes,1999,59(2):347-352. 15ZitzmannS,MierW,SchadA,eta1.Anewprostatecarcinomabind— ingpeptide(DUP一1)fortumorimngandtherapy.ClinCancer Res,2005,11(1):139—146. 16BelimeziMM,PapanastassiouD, MerkouriE,eta1.Growthinhibition ofbreastcancercelllinesoverexpressingHer2/neubyanovelinter- nalizedfullyhumanFabantibodyfragment.CancerImmunolInllnu— nother,2006,55(9):1091—1099. 17WinthropMD,DeNardoSJ,AlbrechtH,eta1.SelectionandCharac— terizationofanti—MUC一1scfvsintendedfortargetedtherapy.Clin CancerRes,2003,9(10):3845-3853. 18ⅡuB,ConradF,MatthewR.eta1.Mappingtumorepitopespaceby directselectionofsingle-chainFvantibodylibrariesonprostatecanc— ercells.CancerRes,2004,64(2):704-710. 19MartyC,Langer-MachovaZ,SigristS,et. a1.Isolationandcharacter- izationofascFvantibodyspecificfortumorendothelialmarker1 (TEM1),anewreagentfortargetedtumortherapy.CancerLett. 2006,235(2):298-308. 20LeeTY,WuHC,TsengYL, eta1.Anovelpeptidespecificallybind— ingtonasopharyngealcarcinomafortargeteddrugdelivery.Cancer Res,2004,64(21):8002-8008. 2